CompletedPhase 4NCT00317980

Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis

Studying Leishmaniasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Brasilia
Principal Investigator
Gustavo S Romero, MD
University of Brasilia
Intervention
Meglumine antimoniate(drug)
Enrollment
280 enrolled
Eligibility
7-50 years · All sexes
Timeline
2006 – 2008

Study locations (1)

Collaborators

Ministry of Health, Brazil

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00317980 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis →

← Back to all trials